Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with mild persistent asthma.

@article{Dempsey2002ComparativeEA,
  title={Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with mild persistent asthma.},
  author={Owen J. Dempsey and Geoff Kennedy and Brian J Lipworth},
  journal={The Journal of allergy and clinical immunology},
  year={2002},
  volume={109 1},
  pages={68-74}
}
BACKGROUND Current guidelines advocate the use of preventative anti-inflammatory therapy for mild persistent asthma. OBJECTIVE We compared the efficacy and anti-inflammatory profiles of a leukotriene receptor antagonist and a low dose of inhaled corticosteroid in patients with mild persistent asthma. METHODS Twenty-one adult patients with mild asthma received 4 weeks of either once-daily inhaled hydrofluoroalkane triamcinolone acetonide (450 microg/day ex-actuator dose) or oral montelukast… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Effect of montelukast pretreatment on inducible nitric oxide synthase mRNA expression in the lungs of antigen-challenged allergic mice.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology • 2003

Similar Papers

Loading similar papers…